Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

LEC Eye Centre

Status: Completed

Conditions: Cataract Senile; Intraocular Lens Complication

Treatments: Device: AcrySof™ IQ Vivity™ Toric intraocular lens

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT06196593

VTLEC

Details and patient eligibility

About

The objective of this study was to evaluate the clinical and patient reported outcomes after bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens.

Full description

This is a prospective interventional case series of 30 patients who underwent cataract surgery and bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens. This study is represented by an Asian cohort of patients and the study evaluations were focused not only on clinical visual outcomes but also on "real-life" patient reported outcomes such as dysphotopsias, spectacle independence and daily visual tasks all of which were measured at 1 month and up to 3 months postoperatively. The objective would be to provide insight into the performance of this intraocular lens in Asian patients.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients aged 18 years or older
• bilateral significant cataracts
• bilateral significant corneal astigmatism

Exclusion criteria

• previous refractive surgery
• amblyopia
• strabismus
• any ocular co-morbidity which could impact on final visual acuity
• pre-existing zonular weakness
• capsular instability or compromise

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

All eyes

Experimental group

Description:

All eyes implanted with AcrySof™ IQ Vivity™ Toric intraocular lens

Treatment:

Device: AcrySof™ IQ Vivity™ Toric intraocular lens